Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized,controlled,prospective phase III clinical trial. The purpose of this
study is to evaluate acute toxicity and efficacy of concurrent cisplatin chemoradiation with
or without capecitabine as adjuvant chemotherapy in Local Advanced Nasopharyngeal Carcinoma
at High Risk of Distant Metastasis.Exploring an Individualized comprehensive treatment plan
which is reasonable,effective,low toxicity and fitting with Modern radiotherapy techniques
for Local Advanced Nasopharyngeal Carcinoma at High Risk of Distant Metastasis.